| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Departments of Neuroscience and 2 Process Development, Amgen, Thousand Oaks, California 91320
Leptin efficacy was compared in obese and lean female CD-1 mice. Body weights in these 10- to 12-mo-old mice ranged from 29.7 to 62.0 g, and leptin levels correlated with body weight. Mice from the lean and obese ends of the weight distribution were treated with daily peripheral leptin injections (1-100 mg/kg) for a 33-day period. The half-maximal effective doses for weight loss and fat reduction were shifted 0.5-0.7 log to the right for obese mice. Leptin was less efficacious at low doses (1-3 mg/kg) in obese mice but equal to or more efficacious in obese than lean mice at high doses (30-100 mg/kg). Leptin's initial effects on weight loss could be explained by appetite suppression in both groups, but its effects on fat reduction were greater in leptin-treated than pair-fed mice, particularly in the lean group. Leptin also prevented the elevations in serum corticosterone and ketones found in pair-fed lean mice. These data allow a quantitative comparison of leptin sensitivity in obese vs. lean CD-1 mice and suggest that in mice where obesity is a function of outbreeding and age, leptin sensitivity is moderately reduced. Furthermore, although appetite suppression has a clear role in leptin's effects on body weight, leptin may also have specific effects on lipid metabolism and mobilization that are different from the metabolic compensations that normally occur with food deprivation.
obese or lean CD-1 mice; half-maximal effective dose; appetite; pair-feeding
This article has been cited by other articles:
|
|
 |
|
  W. A. Banks and C. L. Farrell Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E10 - E15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Dobbins, L. S. Szczepaniak, W. Zhang, and J. D. McGarry Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infusion Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E778 - E787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. McCarthy, W. A. Banks, C. L. Farrell, S. Adamu, C. P. Derdeyn, A. Z. Snyder, R. Laforest, D. C. Litzinger, D. Martin, C. P. LeBel, et al. Positron Emission Tomography Shows that Intrathecal Leptin Reaches the Hypothalamus in Baboons J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen and M. L. Heiman Increased weight gain after ovariectomy is not a consequence of leptin resistance Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E315 - E322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Banks, C. M. Clever, and C. L. Farrell Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1158 - E1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pelleymounter, M. B. Baker, and M. McCaleb Does estradiol mediate leptin's effects on adiposity and body weight? Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E955 - E963. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
